Annji Pharmaceutical Co (ROCO:7754) Cash-to-Debt : 12.76 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Annji Pharmaceutical Co's cash to debt ratio for the quarter that ended in Dec. 2024 was 12.76.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Annji Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Annji Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

ROCO:7754' s Cash-to-Debt Range Over the Past 10 Years
Min: 12.76 Med: 77.32 Max: No Debt
Current: 12.76

During the past 4 years, Annji Pharmaceutical Co's highest Cash to Debt Ratio was No Debt. The lowest was 12.76. And the median was 77.32.

ROCO:7754's Cash-to-Debt is ranked better than
57.11% of 1483 companies
in the Biotechnology industry
Industry Median: 7.56 vs ROCO:7754: 12.76

Annji Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Annji Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Annji Pharmaceutical Co Cash-to-Debt Chart

Annji Pharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

140.29

No Debt

14.35

12.76

Annji Pharmaceutical Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial			No Debt	N/A	14.35	13.76	12.76

Competitive Comparison of Annji Pharmaceutical Co's Cash-to-Debt

For the Biotechnology subindustry, Annji Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annji Pharmaceutical Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Annji Pharmaceutical Co's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Annji Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Annji Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	706.011	/	(5.977	+	49.362)
	=	12.76

Annji Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	706.011	/	(5.977	+	49.362)
	=	12.76

Annji Pharmaceutical Co (ROCO:7754) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Annji Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011

Website

https://www.ajpharm.com

Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines